Classic hallucinogens in the treatment of addictions

Progress in Neuro-psychopharmacology & Biological Psychiatry
Michael P Bogenschutz, Matthew W Johnson

Abstract

Addictive disorders are very common and have devastating individual and social consequences. Currently available treatment is moderately effective at best. After many years of neglect, there is renewed interest in potential clinical uses for classic hallucinogens in the treatment of addictions and other behavioral health conditions. In this paper we provide a comprehensive review of both historical and recent clinical research on the use of classic hallucinogens in the treatment of addiction, selectively review other relevant research concerning hallucinogens, and suggest directions for future research. Clinical trial data are very limited except for the use of LSD in the treatment of alcoholism, where a meta-analysis of controlled trials has demonstrated a consistent and clinically significant beneficial effect of high-dose LSD. Recent pilot studies of psilocybin-assisted treatment of nicotine and alcohol dependence had strikingly positive outcomes, but controlled trials will be necessary to evaluate the efficacy of these treatments. Although plausible biological mechanisms have been proposed, currently the strongest evidence is for the role of mystical or other meaningful experiences as mediators of therapeutic effects. Class...Continue Reading

References

Jun 1, 1973·Archives of General Psychiatry·C Savage, O L McCabe
Mar 1, 1973·The American Journal of Psychiatry·C Roy
Apr 1, 1969·The American Journal of Psychiatry·L E HollisterG Krieger
Jun 15, 1970·JAMA : the Journal of the American Medical Association·W N PahnkeS Grof
Jan 1, 1971·Archives of General Psychiatry·W H McGlothlin, D O Arnold
Jul 1, 1969·The American Journal of Psychiatry·A LudwigR Lazar
Oct 1, 1984·The Journal of Nervous and Mental Disease·R J Strassman
Feb 6, 2004·Pharmacology & Therapeutics·David E Nichols
Mar 30, 2004·Journal of Clinical Psychology·Alyssa A Forcehimes
Mar 10, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Paul J GreschElaine Sanders-Bush
Aug 16, 2005·Pharmacology & Therapeutics·Nora D Volkow, Ting-Kai Li
Sep 10, 2005·Journal of Psychoactive Drugs·Evelyn Doering-SilveiraDartiu Xavier Da Silveira
Nov 8, 2005·Biological Psychiatry·John H HalpernHarrison G Pope
May 18, 2006·Drug and Alcohol Dependence·John R HughesSarah A Lindberg
Nov 30, 2006·Drug and Alcohol Review·Jürgen RehmRobin Room
Apr 24, 2007·Biological Psychiatry·Paul H SoloffWalter H Kaye
May 31, 2007·Proceedings of the National Academy of Sciences of the United States of America·Jean-Claude BéïqueRodrigo Andrade
Aug 31, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ce Zhang, Gerard J Marek
Nov 6, 2007·Biochemical Pharmacology·William E FantegrossiChad J Reissig
Jul 3, 2008·Journal of Psychopharmacology·Mw JohnsonRr Griffiths
Jan 20, 2009·The American Journal of Drug and Alcohol Abuse·Lin LuThomas R Kosten
Nov 6, 2009·Proceedings of the National Academy of Sciences of the United States of America·Kelly A JonesPeter Penzes
Nov 17, 2009·Neuroscience and Biobehavioral Reviews·Udi E GhitzaLin Lu
Feb 4, 2010·PloS One·Thomas S Ray
Jun 18, 2010·Drug and Alcohol Dependence·Josep Maria FábregasJosé Carlos Bouso
Aug 19, 2010·Nature Reviews. Neuroscience·Franz X Vollenweider, Michael Kometer

❮ Previous
Next ❯

Citations

Jun 30, 2016·Therapeutic Advances in Psychopharmacology·Saibal DasSomnath Mondal
Dec 3, 2016·Journal of Psychopharmacology·Clinton E Canal, Kevin S Murnane
Jun 26, 2018·Journal of Psychopharmacology·Tehseen NooraniMatthew W Johnson
Sep 22, 2018·International Review of Psychiatry·Frederick S BarrettMendel Kaelen
Oct 12, 2018·Journal of Clinical Psychopharmacology·Susan Schenk, David Newcombe
Nov 14, 2018·International Review of Psychiatry·Albert Garcia-Romeu, William A Richards
Apr 3, 2019·Reviews in the Neurosciences·Noemi Császár-NagyIstván Bókkon
Oct 16, 2018·Current Molecular Pharmacology·Ricardo Jorge Dinis-OliveiraDiana Dias da Silva
Mar 24, 2018·Frontiers in Pharmacology·Link R Swanson
Nov 20, 2018·Frontiers in Pharmacology·Eline C H M HaijenRobin L Carhart-Harris
Aug 15, 2020·Natural Product Reports·Rishab N IyerDavid E Olson
Sep 1, 2017·Journal of Psychopharmacology·R L Carhart-Harris, D J Nutt
Jul 4, 2019·Drug Metabolism Reviews·Rui Filipe Libânio Osório Marta
Dec 7, 2019·Proceedings of the National Academy of Sciences of the United States of America·Blake A KimmeyJohn A Dani
Feb 9, 2017·The International Journal of Neuropsychopharmacology·Alexander BrysonRichard Kanaan
Feb 22, 2018·Perspectives in Psychiatric Care·Matthew J Begola, Jonathan S Dowben
Sep 4, 2018·Frontiers in Psychology·Christopher TimmermannRobin Carhart-Harris
Jan 23, 2020·Proceedings of the National Academy of Sciences of the United States of America·Matthias ForstmannMolly J Crockett
May 19, 2016·Journal of Psychoactive Drugs·Laurie Cloutier-GillM Eugenia Socias
Sep 21, 2018·Frontiers in Pharmacology·Kenneth AlperK Yaragudri Vinod
Mar 29, 2020·Human Psychopharmacology·Laura OrsoliniDomenico De Berardis
Oct 11, 2016·Journal of Psychoactive Drugs·Noah W SweatPeter S Hendricks
Mar 11, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jakub Benko, Stanislava Vranková
Feb 11, 2020·Frontiers in Psychiatry·Juan José FuentesMarta Torrens
Nov 12, 2020·Journal of Psychopharmacology·Ari Brouwer, Robin Lester Carhart-Harris
Sep 16, 2020·Drug and Alcohol Dependence·Jamie E ParnesRachel A Rebecca
Jan 28, 2021·Expert Review of Clinical Pharmacology·Awais AftabMartha Sajatovic
Dec 11, 2020·Nature·Lindsay P CameronDavid E Olson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.